Supplementary Figures 1-4 from Metabolomics Strategy Reveals Subpopulation of Liposarcomas Sensitive to Gemcitabine Treatment
Daniel Braas, Heather R. Christofk(APLA Health), William D. Tap(Memorial Sloan Kettering Cancer Center), Mirielle Riedinger, Matthias Benz(Scripps Health), Ethan Ahler, Fritz C. Eilber(APLA Health), Kathleen B. Smith, Owen N. Witte(Howard Hughes Medical Institute), David A. Nathanson(APLA Health), Hong Wu(Ministry of Education of the People's Republic of China), Brenna Tam
Cited by 0
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|733
Viral hijacking of cellular metabolism
|BMC Biology|2019|530